Lingyan Yu
Impact in
- Biological Psychiatry top 10%
- Neurology top 10%
- Intracerebral and Subarachnoid Hemorrhage Research
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
- Pharmacology 15
- Antibiotics Pharmacokinetics and Efficacy 11
- Co-authors
- Zhenwei Yu (26 shared papers)John H. Zhang (6 shared papers)Jiping Tang (6 shared papers)Tai Xiang Lu (4 shared papers)Derek Nowrangi (3 shared papers)Tian Wang (3 shared papers)Yuanyuan Lv (1 shared paper)Xiaoyi Sun (1 shared paper)
- Journals
- Frontiers in Pharmacology (7 papers)PLoS ONE (3 papers)Frontiers in Psychiatry (2 papers)Journal of Neuroinflammation (2 papers)Annals of Clinical and Translational Neurology (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Lingyan Yu
53 papers receiving 770 citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Biological Psychiatry 31
- Neurology 74
- Neurology 116
- Pharmaceutical Science 41
- Applied Microbiology and Biotechnology 10
Countries citing papers authored by Lingyan Yu
This map shows the geographic impact of Lingyan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingyan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingyan Yu more than expected).
Fields of papers citing papers by Lingyan Yu
This network shows the impact of papers produced by Lingyan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingyan Yu. The network helps show where Lingyan Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingyan Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 87 | |
| 2 | 2023 | 69 | |
| 3 | 2016 | 67 | |
| 4 | 2017 | 57 | |
| 5 | 2017 | 41 | |
| 6 | 2020 | 40 | |
| 7 | 2020 | 27 | |
| 8 | Targeting epigenetic and post-translational modifications of NRF2: key regulatory factors in disease treatment Hit paper breakdown → | 2025 | 23 |
| 9 | 2020 | 23 | |
| 10 | 2018 | 23 | |
| 11 | 2024 | 22 | |
| 12 | 2020 | 21 | |
| 13 | 2011 | 21 | |
| 14 | 2018 | 20 | |
| 15 | 2024 | 18 | |
| 16 | 2010 | 18 | |
| 17 | 2017 | 17 | |
| 18 | 2021 | 16 | |
| 19 | 2019 | 14 | |
| 20 | 2022 | 13 |
About Lingyan Yu
Lingyan Yu is a scholar working on Molecular Biology, Pharmacology, Epidemiology, Pediatrics, Perinatology and Child Health and Psychiatry and Mental health, having authored 65 papers that have together received 773 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (11 papers), Pharmacological Effects and Toxicity Studies (8 papers), Epilepsy research and treatment (8 papers), Antibiotic Resistance in Bacteria (7 papers), Intracerebral and Subarachnoid Hemorrhage Research (6 papers), Ferroptosis and cancer prognosis (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Analytical Methods in Pharmaceuticals (3 papers). The work is most often cited by research in Biological Psychiatry (31 citations), Neurology (74 citations), Neurology (116 citations), Pharmaceutical Science (41 citations) and Applied Microbiology and Biotechnology (10 citations). Lingyan Yu has collaborated with scholars based in China and United States. Frequent co-authors include Zhenwei Yu, John H. Zhang, Jiping Tang, Tai Xiang Lu, Derek Nowrangi, Tian Wang, Yuanyuan Lv, Xiaoyi Sun, Jing Du and Tingting Sun. Their work appears in journals such as Frontiers in Pharmacology, PLoS ONE, Frontiers in Psychiatry, Journal of Neuroinflammation and Annals of Clinical and Translational Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.